Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.

about

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.

P2860

Q47958039-F34134AC-2CCF-4871-8746-308802E09854

P2860

Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.

Item

http://www.wikidata.org/entity/Q39018440

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Tripeptide K

@nl

Tripeptide K(D)PT Is Well Tole ...... Randomized Multicenter Study.

@en

type

Item

label

Tripeptide K

@nl

Tripeptide K(D)PT Is Well Tole ...... Randomized Multicenter Study.

@en

prefLabel

Tripeptide K

@nl

Tripeptide K(D)PT Is Well Tole ...... Randomized Multicenter Study.

@en

P1476

Tripeptide K(D)PT Is Well Tole ...... Randomized Multicenter Study.

@en

P2093

Christian Maaser

http://www.w3.org/2001/XMLSchema#string

Christoph Abels

http://www.w3.org/2001/XMLSchema#string

Gunter Lemmnitz

http://www.w3.org/2001/XMLSchema#string

Torsten Kucharzik

http://www.w3.org/2001/XMLSchema#string

P2860

The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function.

New insights into the functions of alpha-MSH and related peptides in the immune system.

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Laboratory markers in IBD: useful, magic, or unnecessary toys?

Role of the melanocortin system in inflammation.

Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases.

Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore.

Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.

Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease.

Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylates.

P304

261-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000001000

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28092306

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.

about

P2860

P2860

Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921